2013 - CTS 2013 Congress

This page contains exclusive content for the member of the following sections: TTS, CTS

Plenary: Mesenchymal stem cells in regenerative medicine: opportunities and challenges

25.4 - Mesenchymal Stem Cells to Improve Organ Transplantation Outcomes: Initial Clinical Results

Presenter: Antonello , Pileggi , Miami, United States
Authors: Antonello Pileggi

The widespread application of organ transplantation to the large population of patients with end-stage organ failure who are in dire need of its benefits is currently being hampered by a number of challenges. Amongst them are the shortage of organs for transplantation and the need for life-long immunosuppression with the associated untoward side effects. The field of regenerative medicine is rapidly evolving, thus creating exciting opportunities toward the development of novel therapeutic protocols aimed at ameliorating, reducing, modifying, correcting and curing medical conditions. Mesenchymal stromal (stem) cells (MSC) are appealing for inclusion in organ transplantation protocols because of the increasing body of evidence in support of their beneficial properties both in tissue repair and for the modulation of immunity. We will review the encouraging results of the recent clinical trials on the use of MSC to improve organ transplantation outcomes.

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.



Staff Directory
This email address is being protected from spambots. You need JavaScript enabled to view it.


The Transplantation Society
International Headquarters
505 Boulevard René-Lévesque Ouest
Suite 1401
Montréal, QC, H2Z 1Y7